Evoke Pharma Inc (EVOK)
0.4775
+0.02
(+4.95%)
USD |
NASDAQ |
Apr 23, 16:00
0.4775
0.00 (0.00%)
After-Hours: 20:00
Evoke Pharma Profit Margin (Quarterly): -118.6% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -118.6% |
| September 30, 2023 | -108.4% |
| June 30, 2023 | -165.1% |
| March 31, 2023 | -276.8% |
| December 31, 2022 | -226.4% |
| September 30, 2022 | -242.0% |
| June 30, 2022 | -483.6% |
| Date | Value |
|---|---|
| March 31, 2022 | -519.5% |
| December 31, 2021 | -463.8% |
| September 30, 2021 | -211.7% |
| June 30, 2021 | -968.0% |
| March 31, 2021 | -2.88K% |
| December 31, 2020 | -9.85K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-9.85K%
Minimum
Dec 2020
-108.4%
Maximum
Sep 2023
-1.27K%
Average
-276.8%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
| Eton Pharmaceuticals Inc | -30.85% |
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -1.18K% |
| Return on Assets | -85.08% |
| Return on Invested Capital | -137.7% |
| Gross Profit Margin (Quarterly) | 96.48% |
| Operating Margin (Quarterly) | -112.6% |
| Return on Net Operating Assets | -405.7% |